The largest database of trusted experimental protocols

Massarray analyzer 4 system

Manufactured by Agena
Sourced in Germany

The MassARRAY Analyzer 4 System is a lab equipment product designed for high-throughput nucleic acid analysis. It utilizes matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry technology to accurately detect and quantify specific DNA or RNA sequences. The system is capable of processing multiple samples simultaneously, making it a useful tool for researchers and clinicians working in the field of genomics and molecular biology.

Automatically generated - may contain errors

Lab products found in correlation

7 protocols using massarray analyzer 4 system

1

DNA Amplification and Mass Spectrometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Converted DNA was amplified by PCR with use of the HotStart Plus PCR Master Mix (Qiagen; Table 2 in the online Supplemental Data). A 10-L portion of PCR product was in vitro transcribed and cleaved in a basespecific (U-specific) manner with use of RNase A (T-Cleavage MassCleave Kit; Agena Bioscience). The cleaved products were then analyzed by the MALDI-TOF mass spectrometer (MassARRAY Analyzer 4 System; Agena Bioscience).
+ Open protocol
+ Expand
2

Genetic Profiling of Imatinib Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral EDTA-whole blood of each patient before Imatinib treatment were collected. Genomic DNA was extracted by genome TIANGENTM TIANamp Blood DNA Kit (DP348). 33 SNPs, including SNPs in ABCB1 (rs10256836, rs1045642, rs1128503, rs2032582, rs2235040), ABCC2 (rs2273697, rs717620), ABCC4 (rs2274406, rs3765534, rs4148551), ABCG2 (rs2231137, rs2231142, rs72554040), SLC22A1 (rs2282143, rs628031, rs683369), SLC22A3 (rs501470, rs62440430), SLC22A4 (rs272893), SLC22A5 (rs144261584, rs274558), SLCO1A2 (rs12816889, rs5484), SLCO1B3 (rs2053098, rs3764006, rs3834935, rs4149117, rs4149158, rs7311358), EGFR (rs10258429, rs11977388), PDGFRB (rs17110944, rs246388) were genotyped using Agena Sequenom MassArray Analyzer 4 system (MALDI-TOF platform).
+ Open protocol
+ Expand
3

PCR-based Genotyping and ADME Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A specific DNA fragment was generated using PCR and genomic DNA and alleles were subsequently interrogated using a homogeneous mass extension reaction. Genotypes were detected using a MassARRAY® Analyzer 4 system and assigned manually using the Typer Analyzer software (Agena Bioscience, San Diego, CA). The TA repeat genotypes were also incorporated into the ADME PGx Reporter output using a modified ADME PGx Pro database.
+ Open protocol
+ Expand
4

Comprehensive Pharmacogenomic Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
All samples were genotyped for 67 positions (Table 1) using iPLEX Pro chemistry on the MassARRAY® Analyzer 4 System (Agena Biosciences, San Diego, CA, USA). Twenty-nine SNP and indel variants as well as copy number status of the CYP2D6 gene were analyzed using the Agena iPLEX® ADME CYP2D6 Panel v1.0, which is a 3-well assay combining genotyping for SNP and indel variants as well as five assays to determine genomic copy number. This genotyping platform and assay have been previously shown to accurately genotype pharmacogenetic loci in Coriell reference samples.32 (link)CYP2D6 diplotypes and CNV calling for MassArray data were determined using the Agena PGx Report 2.0 Reporter plugin for the Typer Analyzer software (Agena Bioscience). CYP2D6 copy number was estimated from the five copy number assays that are integrated in the CYP2D6 genotyping panel, which is calculated from informative polymorphisms between CYP2D6 and CYP2D7. Variants in the remaining 18 genes in this study were also typed on the MassARRAY® Analyzer 4 System with custom-designed primers using a combination of Agena’s Assay Design Suite (ADS) and Primer3 (ref 33 (link)).
+ Open protocol
+ Expand
5

Genotyping of Pharmacokinetic Gene Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols

Genotyping of pharmacokinetically relevant gene variants (SNPs and star allele
coverage; supplement 2) was performed on a MassArray Analyzer 4 system (Agena
Bioscience GmbH, Hamburg, Germany) based on Agena’s PGx 74 v1.0 Assay,
VeriDose
CYP2D6CNV Assay and an additional self-designed panel using
SpectroCHIP
®-384 Arrays and the iPLEX
®Pro chemistry following the instructions supplied by the manufacturer. Primer
sequences of the self-designed assay are available on request.
Phenotypes were determined according to the CPIC specifications into poor
metabolizers (PM), intermediate metabolizers (IM), normal metabolizers (NM),
rapid metabolizers (RM), and ultrarapid metabolizers (UM)
23
. If no diplotype-phenotype table was
available, diplotypes were used for analyses.
+ Open protocol
+ Expand
6

PRDM8 CpG Site Analysis via MassARRAY

Check if the same lab product or an alternative is used in the 5 most similar protocols
Measurements of all patient data on PRDM8 and its two CpG sites cg19409579 and cg27242132 have been performed with MassARRAY analysis instead of pyrosequencing. This is due to the fact that the PRDM8 region has many CpG sites, and pyrosequencing primers overlapping with CpGs were temperature sensitive and did not provide reliable measurements. With MassARRAY, longer amplicons can be measured thus making primer design outside of CpG-rich regions and analysis of these PRDM8 regions possible. MassARRAY analyses were performed with a MassARRAY Analyzer 4 System (Agena Bioscience, Hamburg, Germany) as previously described [18 (link)] at Varionostic GmbH (Ulm, Germany).
+ Open protocol
+ Expand
7

TLR9 SNP Association with Autoimmunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The single-nucleotide polymorphism (SNP) rs352140 in the TLR9 gene was screened for the association analysis based on the following principles: (1) minor allele frequencies in the Asian population >0.05; (2) p value of Hardy–Weinberg equilibrium >0.05; and (3) reported to be highly associated with the susceptibility to other autoimmune diseases, including SLE and GD, in the Chinese population. The SNP genotypes of individuals were identified by BGI (Beijing Genomics Institute, Shenzhen, China) through the MassARRAY® Analyzer 4 System (Agena Bioscience, San Diego, CA, USA). The following primers were used for amplification in the study: forward, 5’-ACGTTGGATGTGGCTGTTGTAGCTGAGGTC-3’; reverse, 5’-ACGTTGGATGATAAGCTGGACCTCTACCAC-3’. The single base extension primer was 5’-GTCCAGGGCCTCCAGTCG-3’.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!